Anti-Müllerian hormone levels and antral follicle count in women enrolled inin vitrofertilization cycles: Relationship to lifestyle factors, chronological age and reproductive history
- 1 January 2007
- journal article
- Published by Taylor & Francis in Gynecological Endocrinology
- Vol. 23 (8), 486-493
- https://doi.org/10.1080/09513590701532815
Abstract
The aims of this prospective study were to investigate the relationship between anti-Müllerian hormone (AMH) and antral follicle count (AFC), and to determine whether these markers of ovarian reserve correlate with lifestyle factors, ethnicity, chronological age and reproductive history. Participants were 136 normo-ovulatory women undergoing infertility work-up within 3 months of their first ovarian stimulation cycle for in vitro fertilization. On day 3 of a spontaneous menstrual cycle, a blood sample for measurement of plasma AMH levels was taken and a transvaginal ultrasound scan to determine the AFC (follicles measuring 2-5 mm in diameter) was performed. Information about smoking, body mass index, alcohol consumption, ethnic origin, chronological age, age at menarche, years since menarche and gravidity were recorded using a case report form. The main outcome measures were plasma AMH concentrations and total number of small antral follicles (AFC). Median plasma levels of AMH were 2.0 ng/ml (interquartile range 1.1-3.6) and AFC was 10 (interquartile range 7-15). A positive correlation between AMH and AFC (r = 0.54, p < 0.0001) was found. AMH and AFC correlated negatively with age (r = -0.30, p < 0.001 and r = -0.27, p = 0.001 respectively) and number of years since menarche (r = -0.23, p = 0.007 and r = -0.21, p = 0.015 respectively), but not with any of the other measures. Circulating AMH levels and AFC correlated with each other and declined significantly with age. There were only weak, non-significant, correlations with lifestyle factors and reproductive history. These putative markers could be used individually or together to assess the age-related decline of ovarian function in normo-ovulatory candidates for IVF.Keywords
This publication has 35 references indexed in Scilit:
- High reproducibility of serum anti-Müllerian hormone measurements suggests a multi-staged follicular secretion and strengthens its role in the assessment of ovarian follicular statusHuman Reproduction, 2005
- Anti-Müllerian hormone and folliculogenesisMolecular and Cellular Endocrinology, 2005
- Anti‐müllerian hormone as a marker of ovarian reserve*Australian and New Zealand Journal of Obstetrics and Gynaecology, 2005
- Inhibin B and anti‐Mullerian hormone: markers of ovarian response in IVF/ICSI patients?BJOG: An International Journal of Obstetrics and Gynaecology, 2004
- Regulation of ovarian function: the role of anti-Mullerian hormoneReproduction, 2002
- Antimüllerian hormone serum levels: a putative marker for ovarian agingFertility and Sterility, 2002
- Serum müllerian-inhibiting substance levels during normal menstrual cyclesFertility and Sterility, 2000
- TGF-β Family Members and Gonadal DevelopmentTrends in Endocrinology & Metabolism, 1999
- Cellular Localization of Mullerian Inhibiting Substance in the Developing Rat OvaryEndocrinology, 1989
- Production of Anti-Müllerian Hormone: Another Homology between Sertoli and Granulosa CellsEndocrinology, 1984